Innovative Non-Invasive Therapy Kona Medical offers a unique, non-invasive ultrasound-based therapy for hypertension that eliminates the need for traditional invasive procedures and specialized facilities, presenting an opportunity to expand into outpatient settings and primary care clinics seeking less invasive treatment options.

Strong Investor Support With significant backing from leading medical technology investors and $10 million in funding, Kona Medical is positioned for product development and clinical trials, which provides a platform for early partnership and advocacy within the medical device landscape.

FDA Investigational Status As the company’s technology is currently investigational and not yet FDA approved, there is a need for device registration and regulatory collaboration, opening opportunities to engage with regulatory consultants and institutions involved in medical device approval processes.

Growing Market Potential Targeting the large, competitive hypertension treatment market, Kona Medical’s innovative approach could appeal to hospitals, outpatient clinics, and healthcare providers looking for safer, less complex alternatives to existing renal denervation therapies.

Strategic Industry Positioning Given competitors like Medtronic and Boston Scientific with extensive portfolios and global footprints, Kona Medical can differentiate by emphasizing its non-invasive, cost-effective, and safety-focused solution to attract early adopters and enterprise partnerships in medical technology.